Essential Reading - Archives


 

 

ARCHIVE INFORMATION [1999 to 2005]

25 Jan 2005

The MHRA has launched a consultation document, MLX318: Consultation on proposed Herbal Medicines Advisory Committee , inviting comments on updated proposals for the creation of a new advisory committee on herbal medicines. It is proposed that the Herbal Medicines Advisory Committee should be established as a Section 4 committee under the Medicines Act 1968. This Committee would advise Ministers directly on areas for which the Committee is responsible. It is proposed that the Committee's remit would be the registration scheme to be introduced under the Directive on Traditional Herbal Medicinal Products and unlicensed herbal medicines. The closing date for comments is 22 April 2005; the outcome will be published on the MHRA website when available.

30 Apr 2004

Traditional Herbal Medicinal Products Directive (2004/24/EC)

July 2004

The MHRA has produced a question and answer briefing with the most commonly asked questions by the herbal sector about the Directive.

Aug 2004

The MHRA has issued an updated briefing note on sources of evidence of traditional use that may be acceptable under the Directive.

 

Regulation of unlicensed herbal remedies in the United Kingdom made up to meet the needs of individual patients and statutory regulation of herbalists.

2 Mar 2004

The MHRA launched the consultation document MLX 299: Proposals for the reform of the regulation of unlicensed herbal remedies in the United Kingdom made up to meet the needs of individual patients seeking views on a number of outline proposals and ideas for regulatory reform of unlicensed herbal remedies supplied following a one to one consultation by a herbalist. A summary of responses to MLX 299 has been produced.

Mar 2004
Feb 2005

The above MHRA consultation was published in conjunction with a related consultation by the Department of Health on the regulation of Herbal Medicine and Acupuncture Practitioners. The Department of Health consultation: 'Regulation of herbal medicine and acupuncture - proposals for statutory regulation' was followed up with a summary of responses in February 2005.

 

Information and links from 2003 or earlier

1999-2003

Press releases from Herbal Medicinal Products Working Party (HMPWP)
http://www.emea.eu.int/htms/human/hmpwp/hmpwppr.htm

9 Jan 2002

Statement by French Agency for the Safety of Health Products (AFSSAPS) (in French only, regarding Kava)

21 Dec 2001

MCA press release: Voluntary suspension of Kava-kava sales by herbal sector following safety concerns

European Herbal Practitioners Association - links to British and American communications regarding Kava

Nov 2001

MCA: Traditional Ethnic medicines : Public health and compliance with medicines law

Sept 2001

MCA: Review of herbal ingredients for use in unlicensed herbal medicinal products

Sept 2001

The Independent Review Panel for Borderline Products (MCA) - Guidance on requesting a review of a provisional determination issued by the Borderline section of the Medicines Control Agency

27/9/2001

MCA Press Release: Concern over quality and safety standards of traditional Chinese medicines (2001/0448)

24/8/2001

MCA: Licensing of Medicines: What is a medicine/borderline product?

26/7/2001

EMEA: Committee for Proprietary Medicinal Products (CPMP) Note for guidance on specifications: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products

26/7/2001

EMEA: Committee for Proprietary Medicinal Products (CPMP) Note for guidance on quality of herbal medicinal products

10/7/2001

EMEA:Working Party on Herbal Medicinal Products (HMPWP) Points to consider on good agricultural and collection practice for starting materials of herbal origin

Apr 2001

EMEA: Directive on Traditional Medicinal Products, Draft No.2

30/4/2001

MCA: UK response to the 2nd draft of directive on traditional medicinal products

9/1/2001

MCA: Proposal to confirm permanent prohibition in unlicensed medicines of Aristolochia species and herbal ingredients which may be confused with Aristolochia species

1999-2000

http://www.emea.eu.int/htms/human/hmpwp/hmpwpworkingfin.htm Finalised working documents from Herbal Medicinal Products Working Party (HMPWP)

Dec 2000

MCA Guidance Note No.8: A guide to what is a medicinal product

18/12/2000

MCA: Comments in response to the Commission's first draft of a possible Directive on traditionally used medicines

8/11/2000

European Commission: Provisions of a Directive on traditional medicinal products

29/2/2000

St. John's Wort (Hypericum perforatum) interaction information
Letter from Professor A Breckenridge, Chairman of Committee on Safety of Medicines. 29 February 2000
Fact sheet for health care professionals, including specific advice for medicines that have been shown to interact with St John's Wort
Fact sheet for the public

28/7/1999

Department of Health Press Release: Ban on supply of Aristolochia

Some of the documents referred to on this page are pdf documents.

They can be viewed using Adobe Acrobat viewer which can be downloaded free from www.adobe.com.